Study Investigating the Safety and Efficacy of Nalbuphine Extended-Release Tablets (NAL ER) for the Treatment of Cough in Idiopathic Pulmonary Fibrosis (IPF)
Study Investigating the Safety and Efficacy of Nalbuphine Extended-Release Tablets (NAL ER)
top of page
Search
Glenn Hearson
- Nov 17, 2023
Efficacy and Safety of Orvepitant in Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis
We have recently commenced a new study led at Nottingham University Hospitals NHS Trust by Gr Gauri Saini, to assess the efficacy and...
80
Glenn Hearson
- May 25, 2023
Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole
We have just commenced recruiting patients into a new trial which funded by an NIHR HTA Grant with Chief Investigator Professor Andrew...
67
Glenn Hearson
- Aug 26, 2021
Study to assess remote monitoring of patients with an interstitial lung disease
We will be shortly commencing a new study to find out if it is practical for patients with a fibrotic lung disease, to take their own...
154
Glenn Hearson
- Apr 12, 2021
Understanding Patient Priorities for Scientific Research on Pulmonary Fibrosis
Dr Amanda Goodwin , Dr Amanda Tatler and Dr Rachel Clifford , along with many other researchers in Translational Medical Science at the...
218
Glenn Hearson
- Oct 5, 2020
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease: An International Multicenter Study
103
Glenn Hearson
- Mar 30, 2020
Nottingham Covid Research Group website launched
The Group will nvestigate the pathogenesis, treatment and complications of lung disease caused by the SARS-CoV-2 virus
508
Glenn Hearson
- Dec 13, 2019
Midlands Interstitial Lung Disease (MILD) Educational Meeting
This exciting event was organised by Natalie Stevenson, Lucy Howard and Dr Fasihul Khan from the ILD team of the University of Nottingham
153
bottom of page